Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

Performance of NVO Novo Nordisk A/S | 49.3% in 12m

Compare NVO with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Novo Nordisk A/S with its related Sector/Index XLV

Compare Novo Nordisk A/S with its related Sector/Index XLV

Performance Duell NVO vs XLV

TimeFrame NVO XLV
1 Day -1.93% -0.31%
1 Week 1.31% 1.75%
1 Month -2.24% -3.02%
3 Months 20.5% 1.93%
6 Months 30.0% 11.24%
12 Months 49.3% 6.02%
YTD 24.2% 1.87%
Rel. Perf. 1m 0.10
Rel. Perf. 3m 1.95
Rel. Perf. 6m 1.63
Rel. Perf. 12m 3.46

Is Novo Nordisk A/S a good stock to buy?

Yes, based on ValueRay Fundamental Analyses, Novo Nordisk A/S (NYSE:NVO) is currently (April 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 86.03 and therefor a positive outlook according to fundamental data.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NVO as of April 2024 is 155.85. This means that NVO is currently undervalued and has a potential upside of +23.53% (Margin of Safety).

Is NVO a buy, sell or hold?

  • Strong Buy: 5
  • Buy: 3
  • Hold: 2
  • Sell: 0
  • Strong Sell: 1
Novo Nordisk A/S has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy NVO.
Values above 0%: NVO is performing better - Values below 0%: NVO is underperforming

Compare NVO with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 0.34% 0.52% 9.87% 25.01%
US NASDAQ 100 QQQ 1.15% 1.86% 10.81% 13.37%
US Dow Jones Industrial 30 DIA -0.65% -0.13% 12.95% 33.58%
German DAX 40 DBXD -0.46% -1.20% 8.55% 35.93%
UK FTSE 100 ISFU -0.87% -2.35% 16.99% 44.01%
Shanghai Shenzhen CSI 300 CSI 300 2.79% -1.62% 30.33% 64.08%
Hongkong Hang Seng HSI -4.49% -0.65% 36.87% 70.31%
Japan Nikkei 225 EXX7 1.44% 4.04% 13.04% 30.73%
India NIFTY 50 INDA -0.73% -5.15% 11.15% 19.61%
Brasil Bovespa EWZ -1.41% 1.67% 23.88% 31.88%

NVO Novo Nordisk A/S vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 0.21% -1.38% 9.93% 7.69%
Consumer Discretionary XLY 0.23% 2.11% 16.09% 30.14%
Consumer Staples XLP -2.17% -2.90% 16.21% 47.62%
Energy XLE -0.88% -5.38% 18.21% 33.93%
Financial XLF -2.29% -1.90% 1.30% 22.98%
Health Care XLV -0.44% 0.78% 18.79% 43.25%
Industrial XLI 0.50% -0.38% 5.62% 26.18%
Materials XLB 2.05% 1.11% 11.53% 38.31%
Real Estate XLRE -1.24% 2.52% 16.64% 46.93%
Technology XLK 1.72% 2.79% 9.74% 13.56%
Utilities XLU -2.84% -6.26% 14.94% 50.60%
Aerospace & Defense XAR -0.61% 0.71% 11.67% 32.21%
Biotech XBI 2.15% 7.18% 4.89% 45.90%
Homebuilder XHB -0.53% 4.07% -15.18% 0.56%
Retail XRT -1.32% 3.01% 5.35% 31.79%

NVO Novo Nordisk A/S vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 0.38% -4.66% 26.51% 34.27%
Natural Gas UNG 1.45% 2.28% 78.45% 99.34%
Gold GLD 3.56% -9.03% 12.71% 33.13%
Silver SLV 4.99% -12.51% 11.57% 41.38%
Copper CPER -1.41% -13.38% 6.39% 34.57%

Returns of NVO vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 2.30% 2.90% 24.41% 62.30%
iShares High Yield Corp. Bond HYG 0.31% -1.41% 21.31% 41.22%
Does Novo Nordisk A/S outperform its market, is NVO a Sector Leader?
Yes, over the last 12 months Novo Nordisk A/S (NVO) made 49.27%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.02%.
Over the last 3 months NVO made 20.53%, while XLV made 1.93%.
Period NVO XLV S&P 500
1 Month -2.24% -3.02% -2.76%
3 Months 20.53% 1.93% 4.45%
12 Months 49.27% 6.02% 24.26%